|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
51,478 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
20,101 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
19,243 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
18,337 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
17,883 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
13,579 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
10,653 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
800 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
40,183 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,853 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,674 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,555 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,964 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,218 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,605 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,196 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,555 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
5,040 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,155 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
37,240 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,634 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,548 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,218 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,853 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,674 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,555 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
30,008 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,605 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,964 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
12,292 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
20,101 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
19,243 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
18,337 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
17,883 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
15,668 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
61,631 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
15,668 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
17,883 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
18,337 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
25,016 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
26,548 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
67,299 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
10,653 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,615 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
192,056 |
0
(0%)
|
1%
|
|
-
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
89,127 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
84,669 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
73,349 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
74,515 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
62,674 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
45,073 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,605 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,555 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,674 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,853 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
2,964 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,218 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
13,978 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
John D. Manders
|
VP Finance, Corp. Controller |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
3,160 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
VP Finance, Corp. Controller |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
8,155 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
John D. Manders
|
VP Finance, Corp. Controller |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
1,740 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
VP Finance, Corp. Controller |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
1,862 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
VP Finance, Corp. Controller |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,584 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
VP Finance, Corp. Controller |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
4,810 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
8,356 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
12,292 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
5,463 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
34,703 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
29,582 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
28,864 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
18,337 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
17,883 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
15,668 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
20,859 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
21,040 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
11,538 |
0
|
-
|
|
-
|
Employee Stock Options (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
17,883 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
18,337 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Nov 2025 |
19,243 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. |
18 Feb 2025 |
2,640 |
16,093
(0%)
|
0%
|
27.3 |
72,072
|
Common Stock |
|
Lisa Wipperman Heine
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Feb 2025 |
2,640 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.09 per share. |
18 Feb 2025 |
2,115 |
13,978
(0%)
|
0%
|
34.1 |
72,100
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. |
14 Feb 2025 |
5,275 |
34,232
(0%)
|
0%
|
27.3 |
144,008
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Feb 2025 |
5,275 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.10 per share. |
14 Feb 2025 |
4,224 |
30,008
(0%)
|
0%
|
34.1 |
144,038
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Feb 2025 |
5,275 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. |
13 Feb 2025 |
5,275 |
44,399
(0%)
|
0%
|
27.3 |
144,008
|
Common Stock |
|
David R. Dantzker
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.16 per share. |
13 Feb 2025 |
4,216 |
40,183
(0%)
|
0%
|
34.2 |
144,019
|
Common Stock |
|
Susan E. Knight
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. |
24 Jan 2025 |
7,358 |
42,506
(0%)
|
0%
|
27.3 |
200,873
|
Common Stock |
|
Susan E. Knight
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.15 per share. |
24 Jan 2025 |
5,266 |
37,240
(0%)
|
0%
|
38.2 |
200,898
|
Common Stock |
|
Susan E. Knight
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Jan 2025 |
7,358 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Arens Timothy J.
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
1,265 |
67,299
(0%)
|
0%
|
39.9 |
50,486
|
Common Stock |
|
John D. Manders
|
VP Finance, Corp. Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
152 |
8,155
(0%)
|
0%
|
39.9 |
6,066
|
Common Stock |
|
Gordon Weber S.
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
668 |
21,040
(0%)
|
0%
|
39.9 |
26,660
|
Common Stock |
|
Woodwick Sides Teri
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
946 |
34,703
(0%)
|
0%
|
39.9 |
37,755
|
Common Stock |
|
Olson W. Charles
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
959 |
51,478
(0%)
|
0%
|
39.9 |
38,274
|
Common Stock |
|
J. Stich Joseph
|
SVP of HR, President IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
1,034 |
61,631
(0%)
|
0%
|
39.9 |
41,267
|
Common Stock |
|
R. Gary Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. |
04 Dec 2024 |
4,248 |
192,056
(1%)
|
0%
|
39.9 |
169,538
|
Common Stock |
|
Stich Joseph J.
|
SVP of HR, President IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
1,655 |
62,665
(0%)
|
0%
|
39.5 |
65,290
|
Common Stock |
|
Maharaj Gary R.
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
6,470 |
196,304
(1%)
|
0%
|
39.5 |
255,242
|
Common Stock |
|
W. Charles Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
1,534 |
52,437
(0%)
|
0%
|
39.4 |
60,516
|
Common Stock |
|
J. Arens Timothy
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
1,786 |
68,564
(0%)
|
0%
|
39.5 |
70,458
|
Common Stock |
|
D. John Manders
|
VP Finance, Corp. Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
387 |
8,307
(0%)
|
0%
|
39.4 |
15,267
|
Common Stock |
|
Weber S. Gordon
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
1,030 |
21,708
(0%)
|
0%
|
39.5 |
40,634
|
Common Stock |
|
Woodwick Sides Teri
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. |
30 Nov 2024 |
1,312 |
35,649
(0%)
|
0%
|
39.4 |
51,758
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 39.44 per share. |
26 Nov 2024 |
7,009 |
70,350
(0%)
|
0%
|
39.4 |
276,453
|
Common Stock |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Aug 2024 |
21,285 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. |
21 Aug 2024 |
21,285 |
83,405
(0%)
|
0%
|
33.2 |
706,662
|
Common Stock |
|
Joseph J. Stich
|
SVP of HR, President IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. |
21 Aug 2024 |
19,434 |
63,971
(0%)
|
0%
|
40.1 |
778,526
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Aug 2024 |
61,017 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. |
21 Aug 2024 |
50,569 |
202,582
(1%)
|
0%
|
40.1 |
2,025,794
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. |
21 Aug 2024 |
61,017 |
253,151
(1%)
|
0%
|
33.2 |
2,025,764
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. |
16 Aug 2024 |
16,727 |
53,971
(0%)
|
0%
|
40.1 |
670,084
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Aug 2024 |
18,447 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. |
16 Aug 2024 |
18,447 |
70,698
(0%)
|
0%
|
33.2 |
612,440
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. |
16 Aug 2024 |
16,729 |
77,359
(0%)
|
0%
|
40.1 |
670,164
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. |
16 Aug 2024 |
18,447 |
94,088
(0%)
|
0%
|
33.2 |
612,440
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Aug 2024 |
18,447 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Lisa Heine Wipperman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
3,853 |
3,853
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kalich B. Ronald
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
1,803 |
38,278
(0%)
|
0%
|
|
0
|
Common Stock |
|
Kalich B. Ronald
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
3,853 |
3,853
|
-
|
|
-
|
Stock Option (right to buy) |
|
Knight E. Susan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
1,944 |
35,148
(0%)
|
0%
|
|
0
|
Common Stock |
|
Bedoya H. Jose
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
1,803 |
28,957
(0%)
|
0%
|
|
0
|
Common Stock |
|
Dantzker David R.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
1,803 |
39,124
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose Bedoya H.
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. |
08 Feb 2024 |
3,932 |
30,108
(0%)
|
0%
|
23.9 |
94,171
|
Common Stock |
|
Bedoya H. Jose
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Feb 2024 |
3,932 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
E. Knight Susan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
4,155 |
4,155
|
-
|
|
-
|
Stock Option (right to buy) |
|
R. David Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
3,853 |
3,853
|
-
|
|
-
|
Stock Option (right to buy) |
|
Heine Lisa Wipperman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
1,803 |
13,453
(0%)
|
0%
|
|
0
|
Common Stock |
|
Bedoya H. Jose
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.89 per share. |
08 Feb 2024 |
2,954 |
27,154
(0%)
|
0%
|
31.9 |
94,203
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2024 |
3,853 |
3,853
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dantzker David R.
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. |
19 Jan 2024 |
3,932 |
40,094
(0%)
|
0%
|
23.9 |
94,171
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Jan 2024 |
3,932 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Dantzker David R.
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.97 per share. |
19 Jan 2024 |
2,773 |
37,321
(0%)
|
0%
|
34.0 |
94,199
|
Common Stock |
|
Kalich B. Ronald
|
Director |
Grant, award, or other acquisition of securities at price $ 36.35 per share. |
29 Dec 2023 |
491 |
36,475
(0%)
|
0%
|
36.4 |
17,848
|
Common Stock |
|
B. Ronald Kalich
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.01 per share. |
27 Dec 2023 |
2,545 |
35,984
(0%)
|
0%
|
37.0 |
94,190
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Dec 2023 |
3,932 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald Kalich B.
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. |
27 Dec 2023 |
3,932 |
38,529
(0%)
|
0%
|
23.9 |
94,171
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
20,101 |
20,101
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John Manders D.
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
3,160 |
3,160
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Maharaj R. Gary
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
89,127 |
89,127
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
20,859 |
20,859
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Arens Timothy J.
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
26,548 |
26,548
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
J. Arens Timothy
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
8,323 |
75,641
(0%)
|
0%
|
|
0
|
Common Stock |
|
Stich J. Joseph
|
SVP HR and IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
20,101 |
20,101
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Sides Woodwick
|
SVP, Vascular Interventions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
9,274 |
36,304
(0%)
|
0%
|
|
0
|
Common Stock |
|
Weber Gordon S.
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
6,539 |
22,065
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gary Maharaj R.
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
27,942 |
191,670
(1%)
|
0%
|
|
0
|
Common Stock |
|
Sides Teri Woodwick
|
SVP, Vascular Interventions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
29,582 |
29,582
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Olson W. Charles
|
SVP, Medical Device Coatings |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
6,302 |
52,251
(0%)
|
0%
|
|
0
|
Common Stock |
|
Manders D. John
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
1,486 |
8,319
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Dec 2023 |
6,302 |
61,796
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
3,703 |
163,728
(1%)
|
0%
|
32.8 |
121,532
|
Common Stock |
|
Woodwick Teri Sides
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
465 |
27,878
(0%)
|
0%
|
32.8 |
15,261
|
Common Stock |
|
Woodwick Teri Sides
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
436 |
28,343
(0%)
|
0%
|
32.8 |
14,310
|
Common Stock |
|
Weber S. Gordon
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
565 |
15,526
(0%)
|
0%
|
32.8 |
18,543
|
Common Stock |
|
J. Arens Timothy
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
650 |
69,105
(0%)
|
0%
|
32.8 |
21,333
|
Common Stock |
|
D. John Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
212 |
6,833
(0%)
|
0%
|
32.8 |
6,958
|
Common Stock |
|
Woodwick Teri Sides
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
848 |
27,030
(0%)
|
0%
|
32.8 |
27,831
|
Common Stock |
|
Olson Charles W.
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
693 |
46,791
(0%)
|
0%
|
32.8 |
22,744
|
Common Stock |
|
Manders D. John
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
68 |
7,220
(0%)
|
0%
|
32.8 |
2,232
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
650 |
47,484
(0%)
|
0%
|
32.8 |
21,333
|
Common Stock |
|
Timothy Arens J.
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
1,094 |
67,318
(0%)
|
0%
|
32.8 |
35,905
|
Common Stock |
|
Weber S. Gordon
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
436 |
16,556
(0%)
|
0%
|
32.8 |
14,310
|
Common Stock |
|
Joseph Stich J.
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
747 |
56,402
(0%)
|
0%
|
32.8 |
24,517
|
Common Stock |
|
Maharaj R. Gary
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
2,768 |
167,431
(1%)
|
0%
|
32.8 |
90,846
|
Common Stock |
|
W. Charles Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
842 |
45,949
(0%)
|
0%
|
32.8 |
27,634
|
Common Stock |
|
Stich J. Joseph
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
908 |
55,494
(0%)
|
0%
|
32.8 |
29,801
|
Common Stock |
|
Timothy Arens J.
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
693 |
68,412
(0%)
|
0%
|
32.8 |
22,744
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
701 |
57,149
(0%)
|
0%
|
32.8 |
23,007
|
Common Stock |
|
R. Maharaj Gary
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
2,639 |
170,199
(1%)
|
0%
|
32.8 |
86,612
|
Common Stock |
|
Manders D. John
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
175 |
7,045
(0%)
|
0%
|
32.8 |
5,744
|
Common Stock |
|
Gordon Weber S.
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. |
30 Nov 2023 |
465 |
16,091
(0%)
|
0%
|
32.8 |
15,261
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 31.31 per share. |
30 Jun 2023 |
570 |
34,040
(0%)
|
0%
|
31.3 |
17,847
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 22.78 per share. |
31 Mar 2023 |
784 |
33,470
(0%)
|
0%
|
22.8 |
17,860
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
1,984 |
36,162
(0%)
|
0%
|
|
0
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
4,674 |
4,674
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
2,139 |
32,335
(0%)
|
0%
|
|
0
|
Common Stock |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
5,040 |
5,040
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
1,984 |
32,686
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
4,674 |
4,674
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
1,984 |
26,176
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
4,674 |
4,674
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
1,984 |
11,650
(0%)
|
0%
|
|
0
|
Common Stock |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2023 |
4,674 |
4,674
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 34.12 per share. |
31 Dec 2022 |
523 |
30,702
(0%)
|
0%
|
34.1 |
17,845
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
650 |
41,253
(0%)
|
0%
|
36.1 |
23,485
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
19,243 |
19,243
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
5,535 |
46,096
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
692 |
40,561
(0%)
|
0%
|
36.1 |
25,002
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
19,243 |
19,243
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
702 |
49,609
(0%)
|
0%
|
36.1 |
25,363
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
747 |
48,862
(0%)
|
0%
|
36.1 |
26,989
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
5,535 |
54,397
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
650 |
63,251
(0%)
|
0%
|
36.1 |
23,485
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
25,016 |
25,016
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
7,196 |
69,755
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
692 |
62,559
(0%)
|
0%
|
36.1 |
25,002
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
84,669 |
84,669
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
24,356 |
172,064
(1%)
|
0%
|
|
0
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
2,768 |
147,708
(1%)
|
0%
|
36.1 |
100,008
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
2,639 |
150,476
(1%)
|
0%
|
36.1 |
95,347
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
2,075 |
6,787
(0%)
|
0%
|
|
0
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
4,810 |
4,810
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
69 |
4,887
(0%)
|
0%
|
36.1 |
2,493
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
175 |
4,712
(0%)
|
0%
|
36.1 |
6,323
|
Common Stock |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
28,864 |
28,864
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
8,303 |
28,017
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
465 |
19,714
(0%)
|
0%
|
36.1 |
16,800
|
Common Stock |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
437 |
20,179
(0%)
|
0%
|
36.1 |
15,789
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
465 |
10,240
(0%)
|
0%
|
36.1 |
16,800
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
19,243 |
19,243
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2022 |
5,535 |
16,077
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. |
30 Nov 2022 |
437 |
10,705
(0%)
|
0%
|
36.1 |
15,789
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Sale of securities on an exchange or to another person at price $ 34.89 per share. |
28 Nov 2022 |
4,366 |
24,192
(0%)
|
0%
|
34.9 |
152,321
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Nov 2022 |
4,366 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. |
28 Nov 2022 |
4,366 |
28,558
(0%)
|
0%
|
20.2 |
88,106
|
Common Stock |
|
Charles W. Olson
|
SVP, Medical Device Coatings |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. |
25 Nov 2022 |
471 |
41,903
(0%)
|
0%
|
36.0 |
16,965
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. |
25 Nov 2022 |
586 |
50,311
(0%)
|
0%
|
36.0 |
21,108
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. |
25 Nov 2022 |
543 |
63,901
(0%)
|
0%
|
36.0 |
19,559
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. |
25 Nov 2022 |
2,172 |
153,115
(1%)
|
0%
|
36.0 |
78,235
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. |
25 Nov 2022 |
61 |
4,956
(0%)
|
0%
|
36.0 |
2,197
|
Common Stock |
|
Teri Woodwick Sides
|
SVP, Vascular Interventions |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. |
25 Nov 2022 |
365 |
20,616
(0%)
|
0%
|
36.0 |
13,147
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. |
14 Nov 2022 |
4,366 |
36,951
(0%)
|
0%
|
20.2 |
88,106
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Nov 2022 |
4,366 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Sale of securities on an exchange or to another person at price $ 33.00 per share. |
14 Nov 2022 |
2,773 |
34,178
(0%)
|
0%
|
33.0 |
91,507
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. |
11 Nov 2022 |
4,366 |
32,912
(0%)
|
0%
|
20.2 |
88,106
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Nov 2022 |
4,366 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Sale of securities on an exchange or to another person at price $ 33.48 per share. |
11 Nov 2022 |
2,733 |
30,179
(0%)
|
0%
|
33.5 |
91,511
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 30.40 per share. |
30 Sep 2022 |
587 |
28,546
(0%)
|
0%
|
30.4 |
17,845
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. |
19 Jul 2022 |
15,386 |
50,596
(0%)
|
0%
|
36.7 |
565,128
|
Common Stock |
|
Joseph J. Stich
|
SVP HR and IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Jul 2022 |
19,927 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP HR and IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. |
19 Jul 2022 |
19,927 |
65,766
(0%)
|
0%
|
20.3 |
403,522
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 37.23 per share. |
30 Jun 2022 |
480 |
27,959
(0%)
|
0%
|
37.2 |
17,870
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.91 per share. |
13 May 2022 |
151 |
64,444
(0%)
|
0%
|
35.9 |
5,422
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.33 per share. |
12 May 2022 |
339 |
11,142
(0%)
|
0%
|
34.3 |
11,638
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 45.55 per share. |
01 Apr 2022 |
100 |
155,041
(1%)
|
0%
|
45.6 |
4,555
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 44.97 per share. |
01 Apr 2022 |
3,900 |
155,141
(1%)
|
0%
|
45.0 |
175,399
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 45.33 per share. |
31 Mar 2022 |
394 |
27,479
(0%)
|
0%
|
45.3 |
17,860
|
Common Stock |
|
Susan E. Knight
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. |
28 Feb 2022 |
4,366 |
34,562
(0%)
|
0%
|
20.2 |
88,106
|
Common Stock |
|
Susan E. Knight
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Feb 2022 |
4,366 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale of securities on an exchange or to another person at price $ 44.97 per share. |
28 Feb 2022 |
4,366 |
30,196
(0%)
|
0%
|
45.0 |
196,332
|
Common Stock |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.67 per share. |
12 Feb 2022 |
762 |
6,530
(0%)
|
0%
|
41.7 |
31,753
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
3,555 |
3,555
|
-
|
|
-
|
Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
1,375 |
32,585
(0%)
|
0%
|
|
0
|
Common Stock |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
1,482 |
30,196
(0%)
|
0%
|
|
0
|
Common Stock |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
3,834 |
3,834
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
1,375 |
27,085
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
3,555 |
3,555
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
1,375 |
24,192
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
3,555 |
3,555
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
1,375 |
9,666
(0%)
|
0%
|
|
0
|
Common Stock |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Feb 2022 |
3,555 |
3,555
|
-
|
|
-
|
Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 50.00 per share. |
04 Jan 2022 |
2,500 |
45,839
(0%)
|
0%
|
50 |
125,000
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
18,337 |
18,337
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
650 |
37,822
(0%)
|
0%
|
43.9 |
28,555
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
4,552 |
42,374
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. |
30 Nov 2021 |
5,576 |
28,393
(0%)
|
0%
|
21.3 |
118,825
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Nov 2021 |
5,576 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Sale of securities on an exchange or to another person at price $ 44.00 per share. |
30 Nov 2021 |
5,576 |
22,817
(0%)
|
0%
|
44.0 |
245,350
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
18,337 |
18,337
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
4,552 |
48,339
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
701 |
43,787
(0%)
|
0%
|
43.9 |
30,795
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
650 |
60,043
(0%)
|
0%
|
43.9 |
28,555
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
18,337 |
18,337
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
4,552 |
64,595
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
73,349 |
73,349
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
18,210 |
158,733
(1%)
|
0%
|
|
0
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
2,639 |
140,523
(1%)
|
0%
|
43.9 |
115,931
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
68 |
3,033
(0%)
|
0%
|
43.9 |
2,987
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
4,584 |
4,584
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
1,707 |
4,740
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
436 |
15,942
(0%)
|
0%
|
43.9 |
19,153
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
18,337 |
18,337
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
4,552 |
20,494
(0%)
|
0%
|
|
0
|
Common Stock |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
431 |
6,382
(0%)
|
0%
|
43.9 |
18,934
|
Common Stock |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
910 |
7,292
(0%)
|
0%
|
|
0
|
Common Stock |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
3,667 |
3,667
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. |
30 Nov 2021 |
436 |
6,713
(0%)
|
0%
|
43.9 |
19,153
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
4,552 |
11,265
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2021 |
18,337 |
18,337
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. |
25 Nov 2021 |
471 |
38,821
(0%)
|
0%
|
47.8 |
22,537
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. |
25 Nov 2021 |
349 |
38,472
(0%)
|
0%
|
45.8 |
15,974
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. |
25 Nov 2021 |
586 |
44,923
(0%)
|
0%
|
47.8 |
28,040
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. |
25 Nov 2021 |
435 |
44,488
(0%)
|
0%
|
45.8 |
19,910
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. |
25 Nov 2021 |
544 |
61,042
(0%)
|
0%
|
47.8 |
26,030
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. |
25 Nov 2021 |
349 |
60,693
(0%)
|
0%
|
45.8 |
15,974
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. |
25 Nov 2021 |
2,172 |
144,639
(1%)
|
0%
|
47.8 |
103,930
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. |
25 Nov 2021 |
1,477 |
143,162
(1%)
|
0%
|
45.8 |
67,602
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. |
25 Nov 2021 |
61 |
3,146
(0%)
|
0%
|
47.9 |
2,919
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.78 per share. |
25 Nov 2021 |
45 |
3,101
(0%)
|
0%
|
45.8 |
2,060
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. |
25 Nov 2021 |
948 |
16,649
(0%)
|
0%
|
47.9 |
45,362
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. |
25 Nov 2021 |
271 |
16,378
(0%)
|
0%
|
45.8 |
12,404
|
Common Stock |
|
David R. Dantzker
|
Director |
Sale of securities on an exchange or to another person at price $ 47.01 per share. |
24 Nov 2021 |
3,475 |
30,821
(0%)
|
0%
|
47.0 |
163,360
|
Common Stock |
|
David R. Dantzker
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.56 per share. |
03 Nov 2021 |
2,101 |
34,296
(0%)
|
0%
|
56.6 |
118,833
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Nov 2021 |
5,576 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. |
03 Nov 2021 |
5,576 |
36,397
(0%)
|
0%
|
21.3 |
118,825
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 55.24 per share. |
01 Nov 2021 |
200 |
146,811
(1%)
|
0%
|
55.2 |
11,049
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 54.63 per share. |
01 Nov 2021 |
5,800 |
147,011
(1%)
|
0%
|
54.6 |
316,855
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 56.53 per share. |
01 Oct 2021 |
500 |
152,811
(1%)
|
0%
|
56.5 |
28,267
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 55.97 per share. |
01 Oct 2021 |
5,500 |
153,311
(1%)
|
0%
|
56.0 |
307,831
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 55.60 per share. |
30 Sep 2021 |
337 |
30,821
(0%)
|
0%
|
55.6 |
18,737
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 55.60 per share. |
30 Sep 2021 |
321 |
25,339
(0%)
|
0%
|
55.6 |
17,848
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 57.34 per share. |
15 Sep 2021 |
4,970 |
158,811
(1%)
|
0%
|
57.3 |
284,976
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 56.68 per share. |
15 Sep 2021 |
1,030 |
163,781
(1%)
|
0%
|
56.7 |
58,383
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Sale of securities on an exchange or to another person at price $ 59.75 per share. |
31 Aug 2021 |
1,292 |
39,292
(0%)
|
0%
|
59.8 |
77,197
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.07 per share. |
31 Aug 2021 |
8,410 |
61,586
(0%)
|
0%
|
60.1 |
505,189
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Aug 2021 |
12,498 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. |
31 Aug 2021 |
12,498 |
69,996
(0%)
|
0%
|
23.9 |
299,327
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. |
24 Aug 2021 |
14,276 |
56,552
(0%)
|
0%
|
21.0 |
300,224
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Aug 2021 |
14,276 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Gift of securities by or to the insider at price $ 0.00 per share. |
24 Aug 2021 |
1,500 |
45,314
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.14 per share. |
24 Aug 2021 |
9,738 |
46,814
(0%)
|
0%
|
56.1 |
546,691
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 54.40 per share. |
19 Aug 2021 |
2,500 |
42,276
(0%)
|
0%
|
54.4 |
136,002
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Sale of securities on an exchange or to another person at price $ 54.25 per share. |
11 Aug 2021 |
53 |
3,108
(0%)
|
0%
|
54.2 |
2,875
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. |
11 Aug 2021 |
2,608 |
5,716
(0%)
|
0%
|
23.0 |
59,854
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Sale of securities on an exchange or to another person at price $ 53.33 per share. |
11 Aug 2021 |
2,555 |
3,161
(0%)
|
0%
|
53.3 |
136,261
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Aug 2021 |
2,608 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2021 |
4,430 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.78 per share. |
06 Aug 2021 |
1,663 |
25,018
(0%)
|
0%
|
56.8 |
94,425
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. |
06 Aug 2021 |
4,430 |
26,681
(0%)
|
0%
|
21.3 |
94,403
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.45 per share. |
17 Jul 2021 |
31 |
3,108
(0%)
|
0%
|
53.5 |
1,657
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 54.25 per share. |
30 Jun 2021 |
345 |
30,484
(0%)
|
0%
|
54.2 |
18,716
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 54.25 per share. |
30 Jun 2021 |
329 |
22,251
(0%)
|
0%
|
54.2 |
17,848
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Gift of securities by or to the insider at price $ 0.00 per share. |
20 May 2021 |
1,000 |
44,776
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 53.80 per share. |
20 May 2021 |
2,500 |
45,776
(0%)
|
0%
|
53.8 |
134,506
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.24 per share. |
13 May 2021 |
134 |
57,498
(0%)
|
0%
|
53.2 |
7,134
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.99 per share. |
12 May 2021 |
292 |
6,955
(0%)
|
0%
|
53.0 |
15,473
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Sale of securities on an exchange or to another person at price $ 59.75 per share. |
28 Apr 2021 |
1,508 |
40,584
(0%)
|
0%
|
59.8 |
90,103
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Sale of securities on an exchange or to another person at price $ 59.75 per share. |
16 Apr 2021 |
648 |
42,092
(0%)
|
0%
|
59.8 |
38,718
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Sale of securities on an exchange or to another person at price $ 56.75 per share. |
31 Mar 2021 |
4,759 |
42,740
(0%)
|
0%
|
56.7 |
270,073
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 56.07 per share. |
31 Mar 2021 |
334 |
30,139
(0%)
|
0%
|
56.1 |
18,727
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 56.07 per share. |
31 Mar 2021 |
318 |
21,922
(0%)
|
0%
|
56.1 |
17,830
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 52.67 per share. |
01 Mar 2021 |
999 |
164,713
(1%)
|
0%
|
52.7 |
52,620
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 51.86 per share. |
01 Mar 2021 |
3,001 |
165,712
(1%)
|
0%
|
51.9 |
155,639
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. |
26 Feb 2021 |
9,964 |
56,638
(0%)
|
0%
|
20.3 |
201,771
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.15 per share. |
26 Feb 2021 |
9,139 |
47,499
(0%)
|
0%
|
52.2 |
476,599
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. |
26 Feb 2021 |
3,569 |
46,674
(0%)
|
0%
|
21.0 |
75,056
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Feb 2021 |
9,964 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Feb 2021 |
3,569 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Feb 2021 |
5,576 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Sale of securities on an exchange or to another person at price $ 52.36 per share. |
26 Feb 2021 |
5,576 |
28,714
(0%)
|
0%
|
52.4 |
291,955
|
Common Stock |
|
Susan E. Knight
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. |
26 Feb 2021 |
5,576 |
34,290
(0%)
|
0%
|
21.3 |
118,825
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Feb 2021 |
2,614 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 Feb 2021 |
8,359 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. |
24 Feb 2021 |
7,444 |
57,632
(0%)
|
0%
|
51.7 |
384,855
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. |
24 Feb 2021 |
8,359 |
65,076
(0%)
|
0%
|
20.3 |
169,270
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. |
24 Feb 2021 |
2,614 |
56,717
(0%)
|
0%
|
21.0 |
54,972
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Sale of securities on an exchange or to another person at price $ 50.68 per share. |
23 Feb 2021 |
1,497 |
22,817
(0%)
|
0%
|
50.7 |
75,868
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 52.51 per share. |
16 Feb 2021 |
484 |
48,062
(0%)
|
0%
|
52.5 |
25,414
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 51.50 per share. |
16 Feb 2021 |
2,016 |
48,546
(0%)
|
0%
|
51.5 |
103,823
|
Common Stock |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.17 per share. |
12 Feb 2021 |
449 |
6,566
(0%)
|
0%
|
53.2 |
23,873
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
2,964 |
2,964
|
-
|
|
-
|
Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
1,067 |
29,805
(0%)
|
0%
|
|
0
|
Common Stock |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
3,196 |
3,196
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
1,151 |
28,714
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.17 per share. |
11 Feb 2021 |
1,900 |
21,604
(0%)
|
0%
|
53.2 |
101,023
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
2,964 |
2,964
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Feb 2021 |
4,098 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
1,067 |
19,406
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. |
11 Feb 2021 |
4,098 |
23,504
(0%)
|
0%
|
26.5 |
108,433
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
1,067 |
24,314
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
2,964 |
2,964
|
-
|
|
-
|
Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. |
11 Feb 2021 |
10,311 |
152,453
(1%)
|
0%
|
21.0 |
216,840
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. |
11 Feb 2021 |
44,779 |
224,406
(1%)
|
0%
|
23.9 |
1,072,457
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.86 per share. |
11 Feb 2021 |
56,152 |
168,254
(1%)
|
0%
|
53.9 |
3,024,347
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Feb 2021 |
10,311 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Feb 2021 |
27,174 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Feb 2021 |
44,779 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. |
11 Feb 2021 |
27,174 |
179,627
(1%)
|
0%
|
20.3 |
550,274
|
Common Stock |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
2,964 |
2,964
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Feb 2021 |
1,067 |
8,291
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 44.77 per share. |
01 Feb 2021 |
2,843 |
142,299
(1%)
|
0%
|
44.8 |
127,273
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 45.54 per share. |
01 Feb 2021 |
157 |
142,142
(1%)
|
0%
|
45.5 |
7,150
|
Common Stock |
|
Joseph J. Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 45.00 per share. |
05 Jan 2021 |
2,500 |
50,562
(0%)
|
0%
|
45 |
112,500
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 43.96 per share. |
04 Jan 2021 |
2,000 |
145,142
(1%)
|
0%
|
44.0 |
87,926
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
17,883 |
17,883
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
4,273 |
43,105
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
4,273 |
53,062
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
17,883 |
17,883
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Timothy J. Arens
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
4,273 |
54,103
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
17,883 |
17,883
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
74,515 |
74,515
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
17,361 |
147,142
(1%)
|
0%
|
|
0
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
1,862 |
1,862
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
John D. Manders
|
Corporate Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
667 |
3,033
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
4,273 |
16,994
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
17,883 |
17,883
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
15,648 |
15,648
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
3,739 |
7,015
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
17,883 |
17,883
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
4,273 |
7,033
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
349 |
39,428
(0%)
|
0%
|
38.4 |
13,388
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
596 |
38,832
(0%)
|
0%
|
38.4 |
22,863
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. |
25 Nov 2020 |
471 |
39,777
(0%)
|
0%
|
38.9 |
18,336
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. |
25 Nov 2020 |
586 |
49,964
(0%)
|
0%
|
38.9 |
22,813
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
741 |
48,789
(0%)
|
0%
|
38.4 |
28,425
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
434 |
49,530
(0%)
|
0%
|
38.4 |
16,648
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. |
25 Nov 2020 |
543 |
50,775
(0%)
|
0%
|
38.9 |
21,139
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
349 |
50,426
(0%)
|
0%
|
38.4 |
13,388
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
596 |
49,830
(0%)
|
0%
|
38.4 |
22,863
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
1,969 |
129,781
(0%)
|
0%
|
38.4 |
75,531
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
1,477 |
131,750
(0%)
|
0%
|
38.4 |
56,658
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. |
25 Nov 2020 |
2,172 |
133,227
(0%)
|
0%
|
38.9 |
84,556
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. |
25 Nov 2020 |
61 |
2,411
(0%)
|
0%
|
38.9 |
2,375
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
45 |
2,366
(0%)
|
0%
|
38.4 |
1,726
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. |
25 Nov 2020 |
365 |
14,432
(0%)
|
0%
|
38.9 |
14,209
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. |
25 Nov 2020 |
1,711 |
12,721
(0%)
|
0%
|
38.4 |
65,634
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.86 per share. |
17 Nov 2020 |
2,078 |
23,247
(0%)
|
0%
|
38.9 |
80,751
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Nov 2020 |
3,575 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. |
17 Nov 2020 |
3,575 |
25,325
(0%)
|
0%
|
22.6 |
80,724
|
Common Stock |
|
David Dantzker
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.54 per share. |
10 Nov 2020 |
2,095 |
28,376
(0%)
|
0%
|
38.5 |
80,741
|
Common Stock |
|
David Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. |
10 Nov 2020 |
3,575 |
30,471
(0%)
|
0%
|
22.6 |
80,724
|
Common Stock |
|
David Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Nov 2020 |
3,575 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
David Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 38.91 per share. |
30 Sep 2020 |
417 |
26,896
(0%)
|
0%
|
38.9 |
16,225
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 38.91 per share. |
30 Sep 2020 |
459 |
17,929
(0%)
|
0%
|
38.9 |
17,860
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Gift of securities by or to the insider at price $ 0.00 per share. |
22 Sep 2020 |
1,300 |
50,550
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 45.07 per share. |
01 Sep 2020 |
3,000 |
135,399
(0%)
|
0%
|
45.1 |
135,206
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 46.71 per share. |
19 Aug 2020 |
2,500 |
51,570
(0%)
|
0%
|
46.7 |
116,781
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 47.44 per share. |
03 Aug 2020 |
3,000 |
138,142
(1%)
|
0%
|
47.4 |
142,334
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Jul 2020 |
12,612 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.97 per share. |
22 Jul 2020 |
9,418 |
54,070
(0%)
|
0%
|
45.0 |
423,527
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.58 per share. |
22 Jul 2020 |
12,612 |
63,488
(0%)
|
0%
|
22.6 |
284,779
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.34 per share. |
17 Jul 2020 |
95 |
51,318
(0%)
|
0%
|
45.3 |
4,307
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.35 per share. |
17 Jul 2020 |
31 |
2,339
(0%)
|
0%
|
45.4 |
1,406
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 43.02 per share. |
01 Jul 2020 |
2,000 |
141,142
(1%)
|
0%
|
43.0 |
86,037
|
Common Stock |
|
David Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 43.24 per share. |
30 Jun 2020 |
375 |
26,479
(0%)
|
0%
|
43.2 |
16,215
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 43.24 per share. |
30 Jun 2020 |
413 |
17,470
(0%)
|
0%
|
43.2 |
17,858
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Gift of securities by or to the insider at price $ 0.00 per share. |
18 Jun 2020 |
623 |
50,876
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph Stich
|
SVP, HR and GM, IVD |
Sale of securities on an exchange or to another person at price $ 45.00 per share. |
09 Jun 2020 |
2,500 |
51,499
(0%)
|
0%
|
45 |
112,500
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.18 per share. |
13 May 2020 |
149 |
51,413
(0%)
|
0%
|
35.2 |
5,242
|
Common Stock |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2020 |
11,538 |
11,538
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gordon S. Weber
|
Sr. VP of Legal, GC and Sec. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 May 2020 |
2,760 |
2,760
(0%)
|
0%
|
|
0
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.02 per share. |
03 May 2020 |
131 |
2,370
(0%)
|
0%
|
38.0 |
4,981
|
Common Stock |
|
David Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 33.32 per share. |
31 Mar 2020 |
487 |
26,104
(0%)
|
0%
|
33.3 |
16,227
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 33.32 per share. |
31 Mar 2020 |
536 |
17,057
(0%)
|
0%
|
33.3 |
17,860
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Sale of securities on an exchange or to another person at price $ 37.51 per share. |
20 Feb 2020 |
1,821 |
21,750
(0%)
|
0%
|
37.5 |
68,314
|
Common Stock |
|
David Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
4,218 |
4,218
|
-
|
|
-
|
Stock Option (right to buy) |
|
David Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
1,452 |
25,617
(0%)
|
0%
|
|
0
|
Common Stock |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
1,566 |
27,563
(0%)
|
0%
|
|
0
|
Common Stock |
|
Susan E. Knight
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
4,548 |
4,548
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
4,218 |
4,218
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
1,452 |
16,521
(0%)
|
0%
|
|
0
|
Common Stock |
|
Shawn T. McCormick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
4,218 |
4,218
|
-
|
|
-
|
Stock Option (right to buy) |
|
Shawn T. McCormick
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
1,452 |
9,210
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
4,218 |
4,218
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
1,452 |
23,571
(0%)
|
0%
|
|
0
|
Common Stock |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
1,452 |
7,224
(0%)
|
0%
|
|
0
|
Common Stock |
|
Lisa Wipperman Heine
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Feb 2020 |
4,218 |
4,218
|
-
|
|
-
|
Stock Option (right to buy) |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2020 |
3,276 |
3,276
(0%)
|
0%
|
|
0
|
Common Stock |
|
Nusrath Sultana
|
VP, Clinical Affairs |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2020 |
14,264 |
14,264
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 41.08 per share. |
02 Jan 2020 |
702 |
142,885
(1%)
|
0%
|
41.1 |
28,841
|
Common Stock |
|
David R. Dantzker
|
Director |
Grant, award, or other acquisition of securities at price $ 41.43 per share. |
31 Dec 2019 |
392 |
24,165
(0%)
|
0%
|
41.4 |
16,241
|
Common Stock |
|
Ronald B. Kalich
|
Director |
Grant, award, or other acquisition of securities at price $ 41.43 per share. |
31 Dec 2019 |
431 |
15,069
(0%)
|
0%
|
41.4 |
17,856
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 40.74 per share. |
02 Dec 2019 |
730 |
143,587
(1%)
|
0%
|
40.7 |
29,743
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 40.33 per share. |
02 Dec 2019 |
4,270 |
144,317
(1%)
|
0%
|
40.3 |
172,210
|
Common Stock |
|
Bryan K. Phillips
|
SVP, Gen Counsel & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. |
27 Nov 2019 |
413 |
35,311
(0%)
|
0%
|
41.0 |
16,950
|
Common Stock |
|
Bryan K. Phillips
|
SVP, Gen Counsel & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
687 |
35,724
(0%)
|
0%
|
40.9 |
28,091
|
Common Stock |
|
Bryan K. Phillips
|
SVP, Gen Counsel & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
403 |
36,411
(0%)
|
0%
|
40.9 |
16,479
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
596 |
40,661
(0%)
|
0%
|
40.9 |
24,370
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
349 |
41,257
(0%)
|
0%
|
40.9 |
14,271
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. |
27 Nov 2019 |
413 |
40,248
(0%)
|
0%
|
41.0 |
16,950
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. |
27 Nov 2019 |
413 |
25,263
(0%)
|
0%
|
41.0 |
16,950
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
687 |
25,676
(0%)
|
0%
|
40.9 |
28,091
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
403 |
26,363
(0%)
|
0%
|
40.9 |
16,479
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
435 |
54,948
(0%)
|
0%
|
40.9 |
17,787
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. |
27 Nov 2019 |
445 |
53,762
(0%)
|
0%
|
41.0 |
18,263
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
741 |
54,207
(0%)
|
0%
|
40.9 |
30,299
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
596 |
51,975
(0%)
|
0%
|
40.9 |
24,370
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. |
27 Nov 2019 |
413 |
51,562
(0%)
|
0%
|
41.0 |
16,950
|
Common Stock |
|
Timothy J. Arens
|
Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
349 |
52,571
(0%)
|
0%
|
40.9 |
14,271
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.04 per share. |
27 Nov 2019 |
1,079 |
148,587
(1%)
|
0%
|
41.0 |
44,282
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
1,969 |
149,666
(1%)
|
0%
|
40.9 |
80,512
|
Common Stock |
|
Gary R. Maharaj
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
1,477 |
151,635
(1%)
|
0%
|
40.9 |
60,395
|
Common Stock |
|
John D. Manders
|
Corporate Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
45 |
2,404
(0%)
|
0%
|
40.9 |
1,840
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
271 |
14,194
(0%)
|
0%
|
40.9 |
11,081
|
Common Stock |
|
Teri Woodwick Sides
|
Senior VP and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.89 per share. |
27 Nov 2019 |
721 |
14,465
(0%)
|
0%
|
40.9 |
29,482
|
Common Stock |
|
Bryan K. Phillips
|
SVP, Gen Counsel & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. |
25 Nov 2019 |
3,581 |
36,814
(0%)
|
0%
|
42 |
150,402
|
Common Stock |
|
Bryan K. Phillips
|
SVP, Gen Counsel & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
7,852 |
40,395
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
13,579 |
13,579
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
3,095 |
41,606
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
7,852 |
42,092
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles W. Olson
|
Senior VP of Bus Dev, Med Dev |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. |
25 Nov 2019 |
3,581 |
38,511
(0%)
|
0%
|
42 |
150,402
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
3,537 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
David R. Dantzker
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. |
25 Nov 2019 |
1,716 |
23,773
(0%)
|
0%
|
42 |
72,072
|
Common Stock |
|
David R. Dantzker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.37 per share. |
25 Nov 2019 |
3,537 |
25,489
(0%)
|
0%
|
20.4 |
72,049
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
1,904 |
23,195
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
15,668 |
15,668
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gregg Sutton
|
VP of Research and Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
8,356 |
8,356
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Gregg Sutton
|
VP of Research and Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
3,571 |
26,766
(0%)
|
0%
|
|
0
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. |
25 Nov 2019 |
3,581 |
21,291
(0%)
|
0%
|
42 |
150,402
|
Common Stock |
|
Gregg Sutton
|
VP of Research and Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
7,852 |
24,872
(0%)
|
0%
|
|
0
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.37 per share. |
25 Nov 2019 |
3,537 |
23,835
(0%)
|
0%
|
20.4 |
72,049
|
Common Stock |
|
Jose H. Bedoya
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
3,537 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Jose H. Bedoya
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. |
25 Nov 2019 |
1,716 |
22,119
(0%)
|
0%
|
42 |
72,072
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
7,852 |
56,676
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
15,668 |
15,668
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Joseph J. Stich
|
VP and GM, IVD |
Gift of securities by or to the insider at price $ 0.00 per share. |
25 Nov 2019 |
1,000 |
55,383
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Nov 2019 |
3,571 |
56,383
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joseph J. Stich
|
VP and GM, IVD |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.00 per share. |
25 Nov 2019 |
3,864 |
52,812
(0%)
|
0%
|
42 |
162,288
|
Common Stock |